Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

521
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
521
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

76
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
76
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

534
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
534
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

1.1K
The pathophysiology of pneumonia involves the following steps:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

461
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
461

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiscale computational evaluation of marine fungal metabolites containing iminohydantoin-like scaffolds as anti-Alzheimer drug candidates.

SAR and QSAR in environmental research·2026
Same author

Correction: Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.

Techniques in coloproctology·2026
Same author

Integration of genomic aberrations to predict clinical outcomes for patients with gastroesophageal adenocarcinoma receiving neoadjuvant chemotherapy.

ESMO gastrointestinal oncology·2026
Same author

Consequences of patient denial at first exemption request for cardiac transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same author

Safety and Efficacy of Bivalirudin in Female Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.

Mymensingh medical journal : MMJ·2025
Same author

Closing the internal opening with a rectal advancement flap increases the efficacy of mesenchymal stem cell injection for complex Crohn's disease anal fistulas.

Techniques in coloproctology·2024
Same journal

Retraction Note: Can the endometrioma be an obstacle to complete oocyte retrieval in IVF cycles? A retrospective study.

European review for medical and pharmacological sciences·2026
Same journal

Retraction Note: A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients.

European review for medical and pharmacological sciences·2026
Same journal

Retraction Note: Oxycodone inhibits myocardial cell apoptosis after myocardial ischemia-reperfusion injury in rats via RhoA/ROCK1 signaling pathway.

European review for medical and pharmacological sciences·2026
Same journal

Intracoronary stem cell transplant in ischemic heart disease: a meta-analysis of randomized trials.

European review for medical and pharmacological sciences·2026
Same journal

From models to medicine: advanced preclinical systems and AI enabling RNA therapeutics in triple-negative breast cancer.

European review for medical and pharmacological sciences·2026
Same journal

Association of serum asprosin levels with obesity indices and metabolic parameters in adults.

European review for medical and pharmacological sciences·2026
See all related articles

Related Experiment Video

Updated: Oct 26, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

815

Plasma convalescent decrease mortality in COVID-19 patients: a systematic review and meta-analysis.

A Yuwono Soeroto1, A Purwiga, A Alam

  • 1Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin Hospital, Bandung, Indonesia. aysoeroto@yahoo.co.id.

European Review for Medical and Pharmacological Sciences
|August 2, 2021
PubMed
Summary
This summary is machine-generated.

Convalescent plasma (CP) effectively reduced mortality in severe and critical COVID-19 patients. This meta-analysis found CP use associated with decreased mortality, with generally tolerable adverse effects observed.

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

3.8K

Related Experiment Videos

Last Updated: Oct 26, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

815
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.5K
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

3.8K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Critical Care Medicine

Background:

  • COVID-19 poses a significant global health threat, particularly for severe and critical cases.
  • Convalescent plasma (CP) emerged as a potential therapeutic option for mitigating COVID-19 severity.
  • Understanding the efficacy of CP in reducing mortality is crucial for clinical decision-making.

Purpose of the Study:

  • To systematically evaluate the role of Convalescent Plasma (CP) in reducing mortality among COVID-19 patients.
  • To synthesize evidence from comparative studies investigating CP treatment for COVID-19.

Main Methods:

  • A comprehensive literature search was performed across PubMed, Embase, Medrxiv, and Google Scholar (April-December 2020).
  • Included studies were comparative (retrospective or prospective) with a control group, focusing on mortality as the primary outcome.
  • Eighteen studies involving 5658 patients (2092 treated with CP) were included in this meta-analysis.

Main Results:

  • Convalescent plasma (CP) use was significantly associated with decreased mortality in COVID-19 patients (OR = 0.64; 95% CI 0.49 to 0.84; p<0.001).
  • The meta-analysis demonstrated low statistical heterogeneity (I² = 27.62%).
  • Adverse events were reported in a small number of patients, with no fatal cases linked to CP treatment.

Conclusions:

  • Convalescent plasma (CP) is an effective therapeutic intervention for reducing mortality in severe and critical COVID-19 cases.
  • CP treatment demonstrates a favorable safety profile with tolerable adverse effects.
  • The findings support the use of CP as part of the management strategy for severe COVID-19.